Active Ingredient(s): Insulin Glargine
FDA Approved: * June 11, 2020
Pharm Company: * MYLAN PHARMS INC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Semglee Overview

Insulin glargine, marketed under the names Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[3] It is typically the recommended long acting insulin in the United Kingdom.[4] It is used once a day as an injection just under the skin.[3] Effects generally begin an hour after use.[3] Common side effects include low blood sugar, problems at the site of injection, itchiness, and weig...

Read more Semglee Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Semglee Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Insulin Glargine
  • Injection: 100 Units/ml, 100unit/ml, 300 Units/ml
  • Solution: 300 Units/3ml (100 Units/ml), 300 Units/ml (300 Units/ml), 300units/ml (300units/ml), 450 Units/1.5ml (300 Units/ml), 900 Units/3ml (300 Units/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Semglee: (2 results)

Sorted by National Drug Code
  • 49502-195 Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
  • 49502-196 Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.

Other drugs which contain Insulin Glargine or a similar ingredient: (5 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA